Release Date: 18/06/18 16:59 Summary: Syntonic Investor Q&A Webinar Thu 28 June, 11am AEDT Price Sensitive: No Download Document 241.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%